NO954186L - Plaster med aktive bestanddeler - Google Patents

Plaster med aktive bestanddeler

Info

Publication number
NO954186L
NO954186L NO954186A NO954186A NO954186L NO 954186 L NO954186 L NO 954186L NO 954186 A NO954186 A NO 954186A NO 954186 A NO954186 A NO 954186A NO 954186 L NO954186 L NO 954186L
Authority
NO
Norway
Prior art keywords
patch
active ingredients
vitamin
deriv
contg
Prior art date
Application number
NO954186A
Other languages
English (en)
Other versions
NO954186D0 (no
NO311829B1 (no
Inventor
Wilfried Fischer
Karin Klokkers
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934339400 external-priority patent/DE4339400A1/de
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of NO954186D0 publication Critical patent/NO954186D0/no
Publication of NO954186L publication Critical patent/NO954186L/no
Publication of NO311829B1 publication Critical patent/NO311829B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Laminated Bodies (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO19954186A 1993-04-20 1995-10-19 Plaster med virksomt stoff, i form av et laminat NO311829B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4312818 1993-04-20
DE19934339400 DE4339400A1 (de) 1993-11-18 1993-11-18 Wirkstoffpflaster
PCT/EP1994/001231 WO1994023707A1 (de) 1993-04-20 1994-04-20 Wirkstoffplaster

Publications (3)

Publication Number Publication Date
NO954186D0 NO954186D0 (no) 1995-10-19
NO954186L true NO954186L (no) 1995-10-19
NO311829B1 NO311829B1 (no) 2002-02-04

Family

ID=25925074

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19954186A NO311829B1 (no) 1993-04-20 1995-10-19 Plaster med virksomt stoff, i form av et laminat

Country Status (14)

Country Link
US (2) US5683711A (no)
EP (2) EP0695177B1 (no)
JP (1) JP3489831B2 (no)
AT (2) ATE163262T1 (no)
AU (1) AU678237B2 (no)
CA (1) CA2161004C (no)
DE (2) DE59409873D1 (no)
DK (2) DK0813865T3 (no)
ES (2) ES2164286T3 (no)
FI (1) FI114782B (no)
HU (2) HU223045B1 (no)
NO (1) NO311829B1 (no)
PT (1) PT813865E (no)
WO (1) WO1994023707A1 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
AU718096C (en) 1995-06-07 2001-11-22 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US6316022B1 (en) * 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
DE19533089C1 (de) 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19642043A1 (de) * 1995-10-23 1997-04-24 Hexal Ag Transdermales therapeutisches System (TTS) für die Verabreichung von Wirkstoffen zur Behandlung von Drogenabhängigkeit oder Drogensucht
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
WO1999026571A1 (en) 1997-11-25 1999-06-03 Theratech, Inc. Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
DE19859910C2 (de) * 1998-12-23 2001-03-22 Ratiopharm Gmbh Orales Arzneimittel
ATE404172T1 (de) 1998-12-30 2008-08-15 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
US6417227B1 (en) 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7235397B1 (en) * 2000-04-14 2007-06-26 Gensys, Inc. Methods and compositions for culturing spirochete and treating spirochetal diseases
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
US20020198215A1 (en) * 2000-10-23 2002-12-26 Lino Tavares Terazosin transdermal device and methods
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20040258739A1 (en) * 2001-09-04 2004-12-23 Rudy Susilo Plaster for the treatment of dysfunctions and disorders of nails
SI1513532T1 (sl) * 2002-06-10 2007-08-31 Euro Celtique Sa Sistemi za odstranjevanje priprav za transdermalno oddajanje za preprečevanje zlorabe učinkovin, ki jih vsebujejo
MXPA05008366A (es) * 2003-02-07 2005-11-04 Lohmann Therapie Syst Lts Sistema terapeutico transdermico adecuado para la aplicacion de calor para promover la penetracion de sustancias activas y el uso del mismo.
CZ295826B6 (cs) * 2003-04-28 2005-11-16 Ústav Makromolekulární Chemie Av Čr Materiál pro krytí ran obsahující lapače radikálů
JP2007509951A (ja) * 2003-10-28 2007-04-19 ノーヴェン ファーマシューティカルズ インコーポレイテッド 経皮的なドラッグデリバリーシステムにおける医薬品の損失及び送達を制御するための組成物及び方法
US20050096311A1 (en) * 2003-10-30 2005-05-05 Cns Response Compositions and methods for treatment of nervous system disorders
DE102004059880A1 (de) * 2004-12-10 2006-06-14 Grünenthal GmbH Stabiles, hormonhaltiges (Zwischen-)Produkt
US20080138388A1 (en) * 2005-02-04 2008-06-12 Hisamitsu Pharmaceutical Co., Inc. Transdermal Absorption Patch
US20070018059A1 (en) * 2005-07-25 2007-01-25 Woodcock John E Apparatus for holding a container at an angle
MY148823A (en) * 2007-01-11 2013-06-14 Drossapharm Ag Medically active plaster
US8513323B2 (en) * 2007-06-22 2013-08-20 Kimbery-Clark Worldwide, Inc. Multifunctional silicone blends
CN103200944B (zh) 2010-11-17 2016-05-04 赫克萨尔股份公司 包含丁丙诺啡的经皮治疗系统
EP2968652B1 (en) 2013-03-13 2020-07-22 Avery Dennison Corporation Improving adhesive properties

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7711916A (nl) * 1977-10-29 1979-05-02 Akzo Nv Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JPS59184121A (ja) * 1983-03-31 1984-10-19 Nitto Electric Ind Co Ltd アクリル系膏体
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
CH674618A5 (no) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
JP2857882B2 (ja) * 1988-11-02 1999-02-17 富山化学工業株式会社 ピロキシカムのプラスター剤
DE3902013A1 (de) * 1989-01-25 1990-09-20 Knoll Ag Pflaster zur transdermalen anwendung
JP2875611B2 (ja) * 1990-08-29 1999-03-31 エーザイ株式会社 ケイ酸カルシウム含有外用剤
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
KR930007445A (ko) * 1991-10-23 1993-05-20 원본미기재 국소 적용 배합물의 침투 증가방법
DE4237453C1 (no) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De

Also Published As

Publication number Publication date
AU6569694A (en) 1994-11-08
EP0813865B1 (de) 2001-09-19
NO954186D0 (no) 1995-10-19
ATE163262T1 (de) 1998-03-15
AU678237B2 (en) 1997-05-22
NO311829B1 (no) 2002-02-04
CA2161004C (en) 2004-10-26
HU223045B1 (hu) 2004-03-01
EP0695177A1 (de) 1996-02-07
US5830505A (en) 1998-11-03
CA2161004A1 (en) 1994-10-27
ES2115231T3 (es) 1998-06-16
DK0695177T3 (da) 1998-09-28
DK0813865T3 (da) 2001-11-19
EP0695177B1 (de) 1998-02-18
HU0301253D0 (en) 2003-07-28
FI114782B (fi) 2004-12-31
PT813865E (pt) 2002-02-28
US5683711A (en) 1997-11-04
WO1994023707A1 (de) 1994-10-27
FI954989A (fi) 1995-10-19
HU223042B1 (hu) 2004-03-01
DE59409873D1 (de) 2001-10-25
FI954989A0 (fi) 1995-10-19
DE59405277D1 (de) 1998-03-26
ES2164286T3 (es) 2002-02-16
ATE205706T1 (de) 2001-10-15
HU9502994D0 (en) 1995-12-28
JP3489831B2 (ja) 2004-01-26
JPH09501398A (ja) 1997-02-10
EP0813865A1 (de) 1997-12-29
HUT73668A (en) 1996-09-30

Similar Documents

Publication Publication Date Title
NO954186D0 (no) Plaster med aktive bestanddeler
NO900356D0 (no) Blandinger med forsinket frigjoering.
DE69311556D1 (de) Inhalationspulver enthaltend antistatisches hilfsmittel
FI955215A (fi) Hallitusti vapauttavat oksibutyniinivalmisteet
CY1106984T1 (el) Νεα βιοσυγκολλητικη συνθεση που περιεχει μια βιοσυγκολλητικη πολυφαινολικη πρωτεϊνη, ενα πολυμερες που περιεχει ομαδες υδατανθρακα, φαρμακευτικως αποδεκτα λεπτα νηματα και οι χρησεις τους
DE68917908D1 (de) 4,4'-bis(methacryloylthio)diphenylsulfid und vernetzbare zusammensetzung daraus.
BR9306683A (pt) Adesivo proteináceo curado com aldeído
AU3619295A (en) Antiinflammatory agent for external use
ATE265997T1 (de) Substituierte tetrahydronaphthalin- und dihydronaphthalin-derivate mit einer retinoiden und/oder retinoid antagonist-ähnlichen biologischen aktivität
DE59709386D1 (de) Wirkstoffhaltige Pflaster
ATE212829T1 (de) Feste, wasserfreie, pharmazeutische zubereitungen für vaginale verwendung
KR950701162A (ko) 카르테시안 멀티 캐리어 피드백(cartesian multicarrier feedback)
GB2324091A (en) Metalloproteinase inhibitors
AU8121391A (en) Self-sticking matrix system for the sustained transcutaneous release of piribedil
ATE83668T1 (de) Pflaster zur transdermalen anwendung.
ES2152315T3 (es) Xamoneline tartrato.
FR2655658B1 (fr) Compose lessiviel a base d'un polyphosphate et notamment d'un agent optiquement actif, son procede de preparation et son utilisation en detergence.
DK0579939T3 (da) Phospholipidderivater
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
BR9901387A (pt) Composições para a cura de polìmero.
ES2116399T3 (es) Derivados tiazolicos de alcoxiacrilatos con una actividad fungicida.
MX9403275A (es) Metilendioxi[3,'4':6,7]indolizino-[1,2-b]quinolinonas substituidas.
BR9901390A (pt) Composições para a cura de polìmero
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
ECSP951483A (es) Heteroaril--oxazolidinonas de 5 eslabones que contienen nitrogeno

Legal Events

Date Code Title Description
MK1K Patent expired